1. The Impact of Cancer-Associated Fibroblasts on Drug Resistance, Stemness, and Epithelial-Mesenchymal Transition in Bladder Cancer: A Comparison between Recurrent and Non-Recurrent Patient-Derived CAFs
   Nima Rastegar-Pouyani et al, 2023, Cancer Investigation CrossRef
2. Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
   Chang Yang et al, 2020, Frontiers in Immunology CrossRef
3. CD44 in Ovarian Cancer Progression and Therapy Resistance—A Critical Role for STAT3
   Antons Martincuks et al, 2020, Frontiers in Oncology CrossRef
4. Cancer drug resistance induced by EMT: novel therapeutic strategies
   Javier De Las Rivas et al, 2021, Archives of Toxicology CrossRef
5. Isolation of Normal and Cancer-Associated Fibroblasts
   Katarzyna Zawieracz et al, 2022, Ovarian Cancer CrossRef
6. Exploiting the STAT3 Nexus in Cancer-Associated Fibroblasts to Improve Cancer Therapy
   Amr Allam et al, 2021, Frontiers in Immunology CrossRef
7. Inclusion of cancer-associated fibroblasts in drug screening assays to evaluate pancreatic cancer resistance to therapeutic drugs
   Sarah Brumskill et al, 2023, Journal of Physiology and Biochemistry CrossRef
8. Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential
   Mitchell Acland et al, 2020, Frontiers in Oncology CrossRef
9. Identification of key genes and pathways related to cancer-associated fibroblasts in chemoresistance of ovarian cancer cells based on GEO and TCGA databases
   Li Han et al, 2022, Journal of Ovarian Research CrossRef
10. Effects of Exercise-Induced Changes in Myokine Expression on the Tumor Microenvironment
    Nadira Gunasekara et al, 2024, Sports Medicine International Open CrossRef
11. Mechanisms of cancer cell death induction by paclitaxel: an updated review
    Shuang Zhao et al, 2022, Apoptosis CrossRef
12. Phenotypic Basis for Matrix Stiffness-Dependent Chemoresistance of Breast Cancer Cells to Doxorubicin
    M. Hunter Joyce et al, 2018, Frontiers in Oncology CrossRef
13. PRPF6 promotes metastasis and paclitaxel resistance of ovarian cancer via SNHG16/CEBPB/GATA3 axis
    HAN WANG et al, 2021, Oncology Research CrossRef
14. CXCR4-containing Exosomes Derived From Cancer Associated Fibroblasts Promote Epithelial Mesenchymal Transition in Ovarian Clear Cell Carcinoma
    Fang Zhang et al, 2022, Open Medicine Journal CrossRef
15. The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination
    Sabrina J. Ritch et al, 2022, Frontiers in Endocrinology CrossRef
16. Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment
    Peijie Wu et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
17. CAF-Associated Paracrine Signaling Worsens Outcome and Potentially Contributes to Chemoresistance in Epithelial Ovarian Cancer
    Michael Wessolly et al, 2022, Frontiers in Oncology CrossRef
18. Cancer Associated Fibroblasts Promote Renal Cancer Progression Through a TDO/Kyn/AhR Dependent Signaling Pathway
    Li-bo Chen et al, 2021, Frontiers in Oncology CrossRef
19. The role of IL-6/JAK2/STAT3 signaling pathway in cancers
    Bei Huang et al, 2022, Frontiers in Oncology CrossRef